Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Boost for new cancer therapies

15.12.2006
Scientists have revealed the critical role a key enzyme plays in helping cells divide in what could prove an important breakthrough for new cancer therapies.

Cells divide to form two identical cells as part of the body’s natural development and replenishment processes but when cells divide in an abnormal manner, tumours can develop.

Research has shown that an enzyme called ‘Polo kinase’ is involved in normal cell division but that it also goes into overdrive in cancer helping cells to multiply in an uncontrolled way.

Clinical trials on drugs that block the actions of Polo kinase started in the United States last year but the complete picture of how the enzyme assisted the cell-division process has not been clear until now.

... more about:
»Cancer »Kinase »POLO »enzyme

Writing in the highly respected science journal, Nature, a team of researchers from the Universities of Manchester and Newcastle-upon-Tyne have described a new way in which the enzyme works.

“Enzymes are proteins that speed up or ‘catalyse’ the body’s chemical reactions such as those required for normal cell division,” explained Professor Andrew Sharrocks, lead researcher in Manchester’s Faculty of Life Sciences.

“As its name suggests, the enzyme we have studied is from a group known as kinase enzymes which use a particular chemical – a phosphate – to catalyse the reactions that lead to cell division.

“Our study has identified a new target protein that uses these phosphate groups to switch on genes and alter the properties of cells.

“When the actions of enzymes like Polo kinase go unchecked, cells divide in an uncontrolled manner to form tumours. However, if we block their activity using chemical inhibitors the cells can no longer divide and the cancer cannot grow and spread.”

The identification of a new key step in which Polo kinase functions confirms the choice of this enzyme as a target for anti-cancer drug development and will spur on efforts in this direction.

Indeed, as scientists now have a much greater understanding of the mechanisms involved, it might enable them to either develop more effective drugs or suggest different situations in which the drug can be used.

“Kinase inhibitors are proving to be very effective at killing off rogue cells and trials on patients elsewhere have been promising with fewer toxic effects than current cancer treatments,” said Professor Sharrocks.

“Our research on Polo kinase will help with this line of drug development and hopefully produce more effective kinase-blocking chemicals that will one day treat patients with different types of cancer.”

Aeron Haworth | alfa
Further information:
http://www.manchester.ac.uk

Further reports about: Cancer Kinase POLO enzyme

More articles from Life Sciences:

nachricht Microscope measures muscle weakness
16.11.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht Good preparation is half the digestion
16.11.2018 | Max-Planck-Institut für Stoffwechselforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>